Avrobio Company

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Technology: Atrificial Vectors and Immune Cells, Cell-based gene therapy
Industry: Atrificial Vectors and Immune Cells, Public
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 10
Total Funding: 85000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-02-01
Last Funding Type: Series B

Visit Website
Register and Claim Ownership